0001127602-22-005319.txt : 20220216
0001127602-22-005319.hdr.sgml : 20220216
20220216165015
ACCESSION NUMBER: 0001127602-22-005319
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220214
FILED AS OF DATE: 20220216
DATE AS OF CHANGE: 20220216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arnold Wendy S
CENTRAL INDEX KEY: 0001802649
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39062
FILM NUMBER: 22644301
MAIL ADDRESS:
STREET 1: 19 PRESIDENTIAL WAY
STREET 2: SUITE 203
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Frequency Therapeutics, Inc.
CENTRAL INDEX KEY: 0001703647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472324450
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-315-4600
MAIL ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-14
0001703647
Frequency Therapeutics, Inc.
FREQ
0001802649
Arnold Wendy S
75 HAYDEN AVE
SUITE 300
LEXINGTON
MA
02421
1
Chief People Officer
Common Stock
2022-02-14
4
M
0
15000
A
17702
D
Common Stock
2022-02-15
4
S
0
1168
4.331
D
16534
D
Restricted Stock Unit
2022-02-14
4
M
0
15000
D
Common Stock
15000
15000
D
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
Includes 2,702 shares acquired under the Issuer's Employee Stock Purchase Plan on December 31, 2021.
Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units and does not represent discretionary trades by the Reporting Person.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.28 to $4.40. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
The restricted stock units will vest as to 50% on February 14, 2022 and 50% on July 4, 2022.
/s/ James P. Abely, Attorney-in-Fact for Wendy S. Arnold
2022-02-16
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC):
EXHIBIT 24
POWER OF ATTORNEY
With respect to holdings of and transactions in securities issued by Frequency
Therapeutics, Inc. (the ?Company?), the undersigned hereby constitutes and appo
ints the individuals named on Schedule A attached hereto and as may be amended
from time to time, or any of them signing singly, with full power of substituti
on and resubstitution, to act as the undersigned?s true and lawful attorney-in-
fact to:
1. prepare, execute in the undersigned?s name and on the undersigned?s beha
lf, and submit to the United States Securities and Exchange Commission
(the ?SEC?) a Form ID, including amendments thereto, and any other documents
necessary or appropriate to obtain and/or regenerate codes and passwords
enabling the undersigned to make electronic filings with the SEC of reports
required by Section 16(a) of
the Securities Exchange Act of 1934, as amended, or any rule or regulation of
the SEC;
2. execute for and on behalf of the undersigned, Forms 3, 4, and 5 in
accordance with Section 16 of the Securities Exchange Act of 1934, as amended,
and the rules thereunder;
3. do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form 3, 4,
or 5, complete and execute any amendment or amendments thereto,
and timely file such form with the SEC and any stock exchange or similar
authority; and
4. take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to
, in the best interest of, or legally required by, the undersigned,
it being understood that the documents executed by such attorney-in-fact on
behalf of the undersigned pursuant to this Power of Attorney shall be in such
form and shall contain such terms and conditions as such attorney-in-fact may
approve in such attorney-in-fact?s discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned
might or could do if personally present, with full power of substitution
and resubstitution or revocation, hereby ratifying and confirming all that
such attorney-in-fact, or such attorneys-in-fact substitute or substitutes,
shall lawfully do or cause to be done by virtue of this Power of Attorney and
the rights and powers herein granted.
The undersigned acknowledges that the foregoing attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned?s responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934, as amended.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect
to the undersigned?s holdings of and transactions in securities issued by
the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 4th day of February, 2020.
Signature: /s/ Wendy S. Arnold
Print Name: Wendy S. Arnold
Schedule A
Individuals Appointed as Attorney-in-Fact with Full Power of Substitution
and Resubstitution
Peter Pfreundschuh
James P. Abely